ArticleJugan geon-gang gwa jilbyeong2025
[Eighty-four Years of the Masan National Tuberculosis Hospital: The Journey to Eliminate Tuberculosis and New Challenges Ahead].
Article in Jugan geon-gang gwa jilbyeong, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: This study highlights the role and significance of the Masan National Tuberculosis Hospital (MNTH), Republic of Korea's (ROK) first specialized tuberculosis (TB) hospital, by analyzing its 84-year history and key achievements in the context of the National Tuberculosis Control Program. Methods: A literature review and analysis of internal reports and documents related to the MNTH's history and operations were conducted. Results: The MNTH has focused on managing socioeconomically vulnerable TB patients, including those with multidrug-resistant TB (MDR-TB), the elderly, foreigners, and nonadherent patients. With a specialized medical team and standardized treatment, the MNTH has achieved treatment success rates over 10 percentage points higher than the national average. Through integrated nursing care for severely ill patients, has managed to reduce caregiver burden and economic costs. Additionally, it plays a crucial role in preventing TB transmission through isolation and Directly Observed Treatment, Short-course for nonadherent patients. Leveraging its unique TB specimen bank and biosafety level 3 research facility, the MNTH has made significant contributions to TB research and the development of new diagnostic and therapeutic methods. It also participates in national TB control initiatives, including the "TB Safety Belt" project and regional TB prevention efforts. The MNTH is expanding its role to include national infectious disease response. Conclusions: The MNTH is expected to enhance its expertise in MDR-TB treatment, underserved TB patient management, and diagnostic and therapeutic development. Expanding its function as a national infectious disease institution will contribute significantly to ROK's TB elimination goals and enhance national disease response capabilities.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.